Time to buy GILD. Remesvidir and recently bounced off a low resistance of approximately $61.
Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
Remesvidir recently was said to reduce recovery time from Covid-19. More info: gilead.com/purpose/advancing-global-health/covid-19/about-veklury-remdesivir
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。